Lodo Therapeutics Corporation Information

Lodo Therapeutics discovers and develops novel therapeutics addressing "undruggable" targets with high unmet need by applying its proprietary platform to tap the vast collections of undiscovered molecules encoded in environmental microbial DNA. These drug-like molecules span an enormous range of structural diversity and their biological relevance has been optimized by a billion years of evolution. Lodo's proprietary platform leverages breakthroughs in next-generation sequencing, artificial intelligence/machine learning and synthetic biology to increase the speed and efficiency of natural products drug discovery by orders of magnitude. Following successful initial collaborations with two global partners, Lodo is developing an internal pipeline initially focusing on oncology drugs and is expanding its partnering activities in a range of indications